Kathy Chung
Psychiatry & Neurology / Neurology
Credentials: · ·
History
- 1998–2002
Neurology
- 1990–1994
Doctor of Medicine
Research
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Brain · 2010 · 511 citations
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
Annals of Neurology · 2011 · 338 citations
APOE ε4 increases risk for dementia in pure synucleinopathies
JAMA Neurology · 2013 · 318 citations

37 papers

35 papers

34 papers

24 papers

24 papers
- AH
18 papers

12 papers

10 papers
Grants
- 2019–2025
Preventing Levodopa Induced Dyskinesia in Parkinsonâs Disease with Statins
Department of Veterans Affairs · I01
Contact PI · Portland Va Medical Center
- 2012–2016
Reducing Dyskinesia in Parkinson Disease with Omega-3 Fatty Acids
Department of Veterans Affairs · I21
Contact PI · Portland Va Medical Center
- 2005
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $3.1K · Oregon Health & Science University
Clinical trials
- 2019–2024
Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors
Principal investigator · Completed
VA Office of Research and Development
- 2012–2016
Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids
Principal investigator · Completed · Phase 1
VA Office of Research and Development
- 2010–2020
Natural History of Levodopa-Induced Dyskinesia (LID)
Principal investigator · Withdrawn
Oregon Health and Science University
- 2009–2010
Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease
Principal investigator · Terminated
Oregon Health and Science University



